KR102453319B1 - Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract - Google Patents

Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract Download PDF

Info

Publication number
KR102453319B1
KR102453319B1 KR1020210104865A KR20210104865A KR102453319B1 KR 102453319 B1 KR102453319 B1 KR 102453319B1 KR 1020210104865 A KR1020210104865 A KR 1020210104865A KR 20210104865 A KR20210104865 A KR 20210104865A KR 102453319 B1 KR102453319 B1 KR 102453319B1
Authority
KR
South Korea
Prior art keywords
extract
hankook
inflammatory
whitening
wrinkle
Prior art date
Application number
KR1020210104865A
Other languages
Korean (ko)
Inventor
강현수
임미진
박상주
이석현
최정주
Original Assignee
주식회사 한국화장품제조
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한국화장품제조 filed Critical 주식회사 한국화장품제조
Priority to KR1020210104865A priority Critical patent/KR102453319B1/en
Application granted granted Critical
Publication of KR102453319B1 publication Critical patent/KR102453319B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Abstract

The present invention relates to a fermented extract for anti-oxidant, anti-inflammatory, whitening, anti-wrinkle effects using Lactobacillus kunkeei Hankook-001 strain, a manufacturing method thereof, and a cosmetic composition containing the fermented extract for anti-oxidant, anti-inflammatory, whitening, and anti-wrinkle effects and, more specifically, to a cosmetic composition containing a fermented extract obtained by extracting wild ginseng cultured roots and fermenting the same using the Lactobacillus kunkeei Hankook-001 strain (Accession Number: KCTC 14478BP), wherein the Lactobacillus kunkeei Hankook-001 strain provides anti-oxidant, anti-inflammatory, whitening, and anti-wrinkle effects, a manufacturing method thereof, and a cosmetic composition containing the fermented extract for anti-oxidant, anti-inflammatory, whitening, and anti-wrinkle effects.

Description

락토바실러스 쿤키 Hankook-001 균주를 이용한 항산화, 항염, 미백, 항주름용 발효추출물 및 그 제조 방법, 그 발효추출물을 포함하는 항산화, 항염, 미백, 항주름용 화장료 조성물{Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract}Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunki Hankook-001 strain and manufacturing method thereof, and antioxidant, anti-inflammatory, whitening, and anti-wrinkle cosmetic composition comprising the fermented extract {Fermented extract for antioxidant, anti- inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract}

본 발명은 락토바실러스 쿤키 Hankook-001 균주를 이용한 항산화, 항염, 미백, 항주름용 발효추출물 및 그 제조 방법, 그 발효추출물을 포함하는 항산화, 항염, 미백, 항주름용 화장료 조성물에 관한 것으로, 더욱 구체적으로 산삼 배양근을 추출하고, 락토바실러스 쿤키 Hankook-001 균주(Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP)를 이용하여 발효한 발효추출물을 함유하는 화장료 조성물을 제공함으로써, 항산화, 항염, 미백, 항주름의 효과를 제공할 수 있는 락토바실러스 쿤키 Hankook-001 균주를 이용한 항산화, 항염, 미백, 항주름용 발효추출물 및 그 제조 방법, 그 발효추출물을 포함하는 항산화, 항염, 미백, 항주름용 화장료 조성물에 관한 것이다.The present invention relates to a fermentation extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunki Hankook-001 strain and a method for preparing the same, and to a cosmetic composition for antioxidant, anti-inflammatory, whitening, and anti-wrinkle comprising the fermented extract, and more Specifically, by providing a cosmetic composition containing a fermented extract extracted from wild ginseng cultured roots and fermented using Lactobacillus kunkeei Hankook-001 strain (Accession No.: KCTC 14478BP), antioxidant, anti-inflammatory, whitening , Fermented extract for antioxidant, anti-inflammatory, whitening, anti-wrinkle using Lactobacillus kunki Hankook-001 strain that can provide anti-wrinkle effect and method for manufacturing the same, antioxidant, anti-inflammatory, whitening, anti-wrinkle containing the fermented extract It relates to a cosmetic composition.

인간의 피부는 크게 피부의 겉 표면을 둘러싸고 있는 '표피', 표피 아래에서 혈관, 신경 등의 구조물들을 지지하는 기질을 공급하는 '진피', 그리고 진피와 근육 사이에서 지방을 다량 함유하고 있는 '피하 조직'으로 구성되어 있다. Human skin is largely composed of the 'epithelium' that surrounds the outer surface of the skin, the 'dermis' that supplies the substrate supporting structures such as blood vessels and nerves under the epidermis, and the 'subcutaneous layer' containing a lot of fat between the dermis and the muscles. organization is made up of.

그 중에서도 진피에는 약 70% 내외의 수분을 함유하고 있으며, 표피에는 약 30% 정도의 수분을 함유하고 있다고 알려져 있다.Among them, it is known that the dermis contains about 70% moisture and the epidermis contains about 30% moisture.

하지만, 이는 건강한 사람의 피부 기준에 불과하며 표피의 수분율이 10% 이하로 떨어질 경우, 피부가 거칠어지고 피부 노화가 촉진되는 등 부정적인 영향을 띄게 된다. However, this is only the skin standard of a healthy person, and when the moisture content of the epidermis falls below 10%, the skin becomes rough and skin aging is accelerated.

또한, 건조한 피부가 유지됨에 따라 피부에 대한 트러블과 건선 및 아토피 등 다양한 염증이 유발될 수 있다. In addition, as dry skin is maintained, various inflammations such as skin troubles and psoriasis and atopy may be induced.

한편, 유산균은 인체 내에서 유익한 역할을 하는 세균으로서 탄수화물 같은 당을 발효시켜 유산(젖산)을 생성하는 균으로, 지금까지 400여 종이 발견되었으며, 그 중 상품성이 있는 것은 18종으로 알려져 있다. On the other hand, lactic acid bacteria are bacteria that play a beneficial role in the human body and produce lactic acid (lactic acid) by fermenting sugars such as carbohydrates.

이들 유산균은 면역증강 특히, 위 장관 면역 증강의 생리활성을 가진다고 알려져 있으며, 최근 웰빙 추세에 따라, 먹어서 좋은 식품이 발랐을 때도 좋을 것이라는 사회적 분위기가 조성됨에 따라, 몸에 이로운 다양한 화장품 소재들이 개발되면서 유산균의 배양액이 피부의 보습, 각질층의 턴오버(turn over) 속도 증가, 주름살 완화 등의 효과가 보고되어 있다. These lactic acid bacteria are known to have the physiological activity of enhancing immunity, especially gastrointestinal immunity, and according to the recent well-being trend, as a social atmosphere is created that good food is good to eat, various cosmetic materials beneficial to the body have been developed and lactic acid bacteria have been developed. of the culture medium has been reported to have effects such as moisturizing the skin, increasing the turnover rate of the stratum corneum, and relieving wrinkles.

일례로, 한국공개특허 제1991-0019600호에는 보습 및 활성 산소 제거 능이 있는 화장료용 유산균 배양액에 관한 기술이 개시되어 있으며, 한국공개특허 제2013-0096604호의 경우, 발아곡물의 발효 추출물을 주성분으로 하는 발효 화장품 및 그 제조방법에 관한 기술로서, 유산균을 발효 배양하여 생성되는 산물을 화장료 조성물에 포함하거나, 발아 곡물 등을 특정 속의 유산균으로 발효시켜 얻어진 발효액을 화장료에 배합하여 사용하는 기술이 개시되어 있다.For example, Korean Patent Application Laid-Open No. 1991-0019600 discloses a technology related to a lactic acid bacteria culture medium for cosmetics having moisturizing and active oxygen removal ability, and in the case of Korean Patent Application Laid-Open No. 2013-0096604, a fermented extract of germinated grains as a main component is disclosed. As a technology related to a fermented cosmetic and a method for manufacturing the same, a cosmetic composition containing a product produced by fermenting and culturing lactic acid bacteria, or using a fermented liquid obtained by fermenting germinated grains with lactic acid bacteria of a specific genus into a cosmetic is disclosed. .

그리고, 한국공개특허 제2013-0115943호의 경우는 유산균 파쇄물의 상등액을 포함하는 항염증, 피부미백 및 항노화용 조성물에 관한 기술이 개시되어 있다.And, in the case of Korean Patent Application Laid-Open No. 2013-0115943, a technology related to a composition for anti-inflammatory, skin whitening and anti-aging including a supernatant of lactic acid bacteria lysate is disclosed.

한편, 일반적으로 산삼의 종류는 토양의 천연산삼의 종류는 토양의 자생지의 여건에 따라 천종, 지종 등 18종으로 분류된다고 한다. On the other hand, in general, as for the types of wild ginseng, it is said that the types of natural wild ginseng in the soil are classified into 18 types, such as thousand species and genus species, depending on the conditions of the soil's native habitat.

자연적으로 산에서 나서 씨가 떨어져 생긴 천종(천연산삼), 야생동물이나 조류가 산삼씨를 먹고 산중에 배설하여 자란 지종, 사람이 씨를 뿌려 자란 인종, 이미 자란 인삼을 산에 심은 산양산삼, 사람이 인위적으로 양생시킨 장뇌삼(가삼), 연수를 알 수 없어 오래된 산삼으로 아이처럼 생긴 동자삼 등 산삼의 종류는 많이 있지만 천연산삼은 그 모양새나 약효에서 산양산삼, 가삼 등과는 전혀 다른 모습과 약효를 지니고 있다. Cheonjong (natural wild ginseng), which is naturally born from the mountains and the seeds are dropped, wild animals or birds eat wild ginseng seeds and excreted in the mountains; There are many types of wild ginseng, such as Jangnoe ginseng (Gasam) cured with natural ginseng and Dongja ginseng, which is an old wild ginseng whose number of years is unknown.

또한, 타 식물이 전혀 가지고 있지 않은 사포닌 (saponin) 등 생리활성 물질을 다량함유하고 있어서 면역기능 항진, 암세포 생장억제, 항당뇨작용, 심장강화 및 혈압조절, 간기능 강화, 위장기능 강화, 강장효과, 뇌기능강화, 노화억제, 허약체질 개선 등의 효능이 있으며 약리적인 효능이 매우 뛰어나 오랫동안 동양의 신비한 영약으로 알려져 있다. In addition, it contains a large amount of physiologically active substances such as saponin, which other plants do not have at all. , brain function enhancement, aging suppression, and weak constitution improvement.

산삼의 배양근을 인공적으로 조직배양하여 추출한 추출물이 천연 산삼과 그 성분과 기능이 유사하여 식물조직배양으로부터 얻어진 산삼 배양근을 대상으로 삼았다.Wild ginseng cultured roots obtained from plant tissue culture were targeted because the extracts extracted from cultured roots of wild ginseng artificially had similar components and functions to those of natural wild ginseng.

이러한 산삼 배양근의 약효성분이 인체내로 용이하게 흡수되도록 하며, 인삼에 극미량으로 존재하는 성분들을 강화시키는 방법으로서 유산균을 이용하여 발효하거나 효소를 처리하는 방법등이 사용되고 있다. As a method for making the medicinal ingredients of these wild ginseng cultured roots easily absorbed into the human body, and for strengthening the components present in trace amounts in ginseng, fermentation using lactic acid bacteria or enzyme treatment is used.

본 출원에서는 친환경 시대에 맞추어 상기한 락토바실러스 쿤키 Hankook-001 균주를 이용하여 항산화, 항염, 미백, 항주름에 유용하게 사용될 수 있는 화장료 조성물을 제공하였으며, 이를 통해 제조된 화장품으로써의 효과를 검증하였으며, 이에 락토바실러스 쿤키 Hankook-001 균주를 포함하는 화장료 조성물이 항산화, 항염, 미백, 항주름 효과를 제공할 수 있음을 확인하여 본 출원을 완성하였다.In this application, a cosmetic composition that can be usefully used for antioxidant, anti-inflammatory, whitening, and anti-wrinkle properties by using the Lactobacillus kunki Hankook-001 strain described above in line with the eco-friendly era was provided, and the effect as a cosmetic manufactured through this was verified. , thereby completing the present application by confirming that the cosmetic composition containing the Lactobacillus kunki Hankook-001 strain can provide antioxidant, anti-inflammatory, whitening, and anti-wrinkle effects.

한국공개특허 제1991-0019600호Korean Patent Publication No. 1991-0019600 한국공개특허 제2013-0096604호Korean Patent Publication No. 2013-0096604 한국공개특허 제2013-0115943호Korean Patent Publication No. 2013-0115943

본 발명은 상기와 같은 문제점을 해결하고자 연구 개발된 것으로서, 본 발명의 목적은 항산화, 항염, 미백, 항주름에 효과가 있는 발효추출물의 제조방법을 제공하는데 있다.The present invention has been researched and developed to solve the above problems, and an object of the present invention is to provide a method for producing a fermented extract effective in antioxidant, anti-inflammatory, whitening, and anti-wrinkle.

본 발명의 다른 목적은 락토바실러스 쿤키 Hankook-001(Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP)로 발효한 발효 추출물의 제조방법을 제공함으로써, 화장품 원료로서 우수한 화장료 조성물을 제공하는 것이다. Another object of the present invention is to provide a method for producing a fermented extract fermented with Lactobacillus kunkeei Hankook-001 (Accession No.: KCTC 14478BP), thereby providing an excellent cosmetic composition as a cosmetic raw material.

본 발명은 항산화, 항염, 미백, 항주름에 효과가 있는 발효 추출물의 제조 방법에 있어서, 조직배양으로 얻은 산삼 배양근을 추출하여 산삼 배양근 추출물을 수득하고, 상기 추출물에 락토바실러스 쿤키 Hankook-001(Lactobacillus kunkeei Hankook-001) 균주를 접종하여 발효시킨후, 침전물과 유산균체를 제거하여 발효추출물을 제조하는 것을 특징으로 한다. The present invention relates to a method for producing a fermented extract effective in antioxidant, anti-inflammatory, whitening, and anti-wrinkle, extracting cultured wild ginseng roots obtained by tissue culture to obtain a wild ginseng cultured root extract, and Lactobacillus kunki Hankook-001 (Lactobacillus kunkeei Hankook-001) strain is inoculated and fermented, and the sediment and lactic acid bacteria are removed to prepare a fermentation extract.

본 발명을 통하여 알 수 있는 것과 같이, 락토바실러스 쿤키 Hankook-001 (Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP) 균주를 사용하여 발효한 발효추출물을 함유하는 화장료 조성물은 항산화, 항염, 미백, 항주름의 효과를 발휘한다.As can be seen through the present invention, a cosmetic composition containing a fermented extract fermented using a Lactobacillus kunkeei Hankook-001 (Accession No.: KCTC 14478BP) strain has antioxidant, anti-inflammatory, whitening, It exerts an anti-wrinkle effect.

도 1은 본 발명 락토바실러스 쿤키 Hankook-001(Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP) 동정 결과 16S rRNA 서열 도이다.
도 2는 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 자유라디칼 소거활성을 확인한 결과이다.
도 3은 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 HDF 세포 생존율을 확인한 결과이다.
도 4는 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 B16F0 세포 생존율을 확인한 결과이다.
도 5는 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 RAW 264.7세포 생존율을 확인한 결과이다.
도 6은 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 NO 생성 억제를 확인한 결과이다.
도 7은 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 Melanin assay를 확인한 결과이다.
도 8은 실시예 1 내지 실시예 2의 추출물 또는 발효추출물의 MMP-1 발현을 확인한 결과이다.
도 9는 본 발명 락토바실러스 쿤키 Hankook-001 (Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP) 균주의 기탁을 입증하는 기탁증이다.
1 is a 16S rRNA sequence diagram as a result of identification of Lactobacillus kunkeei Hankook-001 (Accession No.: KCTC 14478BP) of the present invention.
2 is a result confirming the free radical scavenging activity of the extracts or fermentation extracts of Examples 1 to 2.
3 is a result confirming the HDF cell viability of the extracts or fermentation extracts of Examples 1 to 2.
4 is a result confirming the B16F0 cell viability of the extracts or fermentation extracts of Examples 1 to 2.
5 is a result confirming the survival rate of RAW 264.7 cells of the extracts or fermentation extracts of Examples 1 to 2.
6 is a result of confirming the NO production inhibition of the extracts or fermentation extracts of Examples 1 to 2;
7 is a result of confirming the Melanin assay of the extracts or fermentation extracts of Examples 1 to 2.
8 is a result confirming the expression of MMP-1 in the extracts or fermentation extracts of Examples 1 to 2.
Figure 9 is a deposit certificate verifying the deposit of the present invention Lactobacillus kunkeei Hankook-001 ( Lactobacillus kunkeei Hankook-001) (Accession No.: KCTC 14478BP) strain.

이하, 본 발명을 설명한다.Hereinafter, the present invention will be described.

본 발명에 따른 항산화, 항염, 미백, 항주름용 발효 추출물의 제조 방법은,The method for producing a fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle according to the present invention,

조직 배양으로 얻어진 산삼 배양근을 정제수로 추출하여 추출물을 수득하고,The wild ginseng cultured root obtained by tissue culture was extracted with purified water to obtain an extract,

상기 추출물에 기탁번호 KCTC 14478BP의 락토바실러스 쿤키 Hankook-001을 접종하여 발효시킨 후, 침전물과 유산균체를 제거하여 발효추출물을 제조하는 것을 특징으로 한다.It is characterized in that the extract is inoculated with Lactobacillus kunki Hankook-001 of accession number KCTC 14478BP and fermented, and then the precipitate and lactic acid bacteria are removed to prepare a fermented extract.

본 발명에서 최종적으로 얻은 발효추출물은 화장료 조성물 전체에 대해 0.01 ~ 10.0 중량% 함유되는 것이 바람직하며 0.01 중량% 미만으로 포함되는 경우에는 피부에 대한 개선 효과가 미미하고, 10.0 중량%를 초과하는 경우에는 재료 투입량 대비 효율성이 떨어져 경제적이지 못하기 때문에 농도에 따른 실험을 통하여 0.01 ~10.0% 로 한다.The fermentation extract finally obtained in the present invention is preferably contained in an amount of 0.01 to 10.0% by weight based on the total cosmetic composition, and when it is contained in an amount of less than 0.01% by weight, the improvement effect on the skin is insignificant, and when it exceeds 10.0% by weight, Since it is not economical due to the low efficiency compared to the amount of material input, it is set to 0.01 ~ 10.0% through an experiment depending on the concentration.

본 발명에서 락토바실러스 쿤키 Hankook-001(Lactobacillus kunkeei Hankook-001)(기탁번호: KCTC 14478BP) 균주의 배양은 바람직하게는 배양액의 pH를 5.0 내지 7.0, 보다 구체적으로 5.8으로 조정하고, 최적 배양 시간은 12시간 내지 48시간, 보다 구체적으로 44시간, 최적 배양 온도는 27 내지 37℃, 보다 구체적으로 32℃로 배양하는 것을 특징으로 한다.In the present invention, the culture of the Lactobacillus kunkeei Hankook-001 (Accession No.: KCTC 14478BP) strain preferably adjusts the pH of the culture medium to 5.0 to 7.0, more specifically to 5.8, and the optimal culture time is 12 hours to 48 hours, more specifically 44 hours, the optimum culture temperature is characterized in that the culture at 27 to 37 ℃, more specifically 32 ℃.

또한, 본 발명은 상기 화장료 조성물이 샴푸, 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초 화장료 제형;In addition, the present invention relates to a basic cosmetic formulation in which the cosmetic composition is composed of a shampoo, a lotion, a gel, a water-soluble liquid, a cream, an essence, an oil-in-water (O/W) type and a water-in-oil (W/O) type;

수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이새도, 치크칼라 및 아이브로우 펜슬류 중에서 선택된 색조화장료 제형; 중에서 선택되는 어느 하나인 것을 특징으로 한다.a makeup base, foundation, skin cover, lipstick, lip gloss, face powder, two-way cake, eye shadow, cheek color, and eyebrow pencil of a water-in-water or water-in-oil type makeup base; It is characterized in that any one selected from among.

본 발명에서의 용어, '조성물'이란, 바람직하게는 피부외용제 조성물을 의미하고, 피부외용제 조성물이란, 일반적으로 피부에 적용되는 조성물 전부를 의미하고, 의약품,의약부외품, 화장료 등을 포함하는 것이다.As used herein, the term 'composition' preferably refers to a composition for external application for skin, and the composition for external application for skin generally refers to all compositions applied to the skin, and includes pharmaceuticals, quasi-drugs, cosmetics, and the like.

또한, 본 발명의 발효추출물의 유효성분의 피부외용제에 대한 배합량은 조성물 총량을 기준으로 0.01 ~ 10.0% 로 하는 것이 바람직하고, 보다 바람직하게는 0.1 ~ 5.0% 이다.In addition, the blending amount of the active ingredient of the ferment extract of the present invention to the external preparation for skin is preferably 0.01 to 10.0%, more preferably 0.1 to 5.0%, based on the total amount of the composition.

한편, 본 발명에서 "유효성분으로 포함된다"는 의미는 본 발명의 조성물로부터 피부 상태의 개선 효과를 나타낼 수 있는 정도로 조성물에 배양물 여과액이 첨가되는 것을 의미하고, 성분 전달 및 안정화 등을 위하여 다양한 성분을 부성분으로 첨가하여 다양한 형태로 제형화하는 것을 포함하는 의미이다.On the other hand, in the present invention, "included as an active ingredient" means that the culture filtrate is added to the composition to the extent that it can exhibit the effect of improving the skin condition from the composition of the present invention, and for component delivery and stabilization, etc. It is meant to include formulating in various forms by adding various components as sub-components.

이하, 실시예를 통해 본 발명을 좀 더 구체적으로 설명한다. 단, 이들 실시예는 본 발명의 예시적인 기재일 뿐이며, 본 발명의 범위가 이들 실시예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. However, these Examples are only exemplary descriptions of the present invention, and the scope of the present invention is not limited to these Examples.

실시예 1 : 산삼 배양근 발효추출물의 제조Example 1: Preparation of fermented wild ginseng cultured root extract

산삼 배양근 100g을 추출용기에 넣고 정제수 1000g을 넣어 혼합한 다음 90℃에서 3시간 동안 추출하여 추출물을 제조하고 냉각하여 여과하였다. 100 g of cultured wild ginseng root was placed in an extraction container, mixed with 1000 g of purified water, and extracted at 90° C. for 3 hours to prepare an extract, cooled and filtered.

다음으로 배양을 위해서 혼합추출물을 121 ℃에서 15분 간 멸균하였다. Next, the mixed extract was sterilized at 121 °C for 15 minutes for incubation.

멸균이 끝난 다음, 방냉하여 락토바실러스 쿤키 Hankook-001을 접종하여 35℃, 150rpm, 2일간 배양 발효시켜 발효액을 제조하였다. After the sterilization was finished, it was allowed to cool, inoculated with Lactobacillus kunki Hankook-001, and cultured and fermented at 35° C., 150 rpm, for 2 days to prepare a fermentation broth.

이어 상기 발효액을 10,000rpm에서 20분간 원심 분리하여 침전물과 유산규체가 제거된 발효 추출물을 얻었다. Then, the fermentation broth was centrifuged at 10,000 rpm for 20 minutes to obtain a fermented extract from which precipitates and lactic acid silica were removed.

이를 감압농축 및 진공건조하여 분말을 얻었다. This was concentrated under reduced pressure and vacuum dried to obtain a powder.

실시예 2 : 산삼 배양근 추출물의 제조Example 2: Preparation of wild ginseng cultured root extract

산삼 배양근 100g을 추출용기에 넣고 정제수 1000g을 넣어 혼합한 다음 90℃에서 3시간 동안 추출하여 추출물을 제조하고 냉각하여 여과하였다. 100 g of cultured wild ginseng root was placed in an extraction container, mixed with 1000 g of purified water, and extracted at 90° C. for 3 hours to prepare an extract, cooled and filtered.

이를 감압농축 및 진공건조하여 분말을 얻었다.This was concentrated under reduced pressure and vacuum dried to obtain a powder.

실험예 1 : 자유라디칼 소거활성 측정 실험Experimental Example 1: Free radical scavenging activity measurement experiment

상기 실시예 1내지 실시예 2에서 제조한 각 추출물의 자유라디칼 소거활성을 측정하기 위해 DPPH법을 이용하여 자유라디칼 소거 활성을 측정하였다.In order to measure the free radical scavenging activity of each extract prepared in Examples 1 to 2, the free radical scavenging activity was measured using the DPPH method.

DPPH법은 DPPH(2,2-Di(4-tert-octylphenyl)-1-1picrylhydrazyl free radical)라는 유리기를 사용하여 환원력에 의한 자유라디칼 소거활성을 측정한다. The DPPH method measures free radical scavenging activity by reducing power using a free radical called DPPH (2,2-Di(4-tert-octylphenyl)-1-1picrylhydrazyl free radical).

피검물질에 의해 DPPH가 환원되어 흡광도가 감소하는 정도를 공시험액의 흡광도와 비교하여 파장 560nm에서 자유라디칼 소거율을 측정하였다.The degree of decrease in absorbance due to the reduction of DPPH by the test material was compared with the absorbance of the blank test solution, and the free radical scavenging rate was measured at a wavelength of 560 nm.

DPPH 자유라디칼 소거활성 측정을 위하여 농도별로 추출물을 준비하였다. Extracts were prepared for each concentration in order to measure the DPPH free radical scavenging activity.

상기 농도의 추출물을 96웰 플레이트에 각각 넣고, 여기에 100uM 메탄올용액으로 제조된 DPPH를 첨가하여 용액의 총 부피가 200㎕가 되도록 하였다. Each of the extracts of the above concentration was placed in a 96-well plate, and DPPH prepared in 100 uM methanol solution was added thereto so that the total volume of the solution was 200 μl.

이것을 37℃에서 30분간 방치한 후 560nm에서 흡광도를 측정하였다. After leaving this at 37° C. for 30 minutes, absorbance was measured at 560 nm.

그 결과를 표 1과 도 2에 나타내었다. The results are shown in Table 1 and FIG. 2 .

<수학식><Equation>

자유라디칼 소거활성(%)= {100-(B/A)}X100Free radical scavenging activity (%) = {100-(B/A)}X100

A: 본 발명의 시료를 처리하지 않은 대조군 웰의 흡광도A: Absorbance of control wells not treated with the sample of the present invention

B: 본 발명의 시료를 처리한 실험군 웰의 흡광도B: Absorbance of the wells of the experimental group treated with the sample of the present invention

Figure 112021091804447-pat00001
Figure 112021091804447-pat00001

실험예 2 : 시료의 세포독성Experimental Example 2: Cytotoxicity of the sample

상기 실시예 1 내지 2에서 제조한 각 혼합물의 세포독성을 확인하기 위해 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay를 진행하였다. In order to confirm the cytotoxicity of each mixture prepared in Examples 1 and 2, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed.

HDF(Human deraml fibroblast), B16F0, RAW 264.7 cells를 96well plate에 1 × 104 / well로 분주하고 37%, 5% CO2 습윤 배양기에서 18 hr 동안 안정화시켰다.HDF (Human deraml fibroblast), B16F0, RAW 264.7 cells were aliquoted in a 96-well plate at 1 × 104 / well and stabilized for 18 hr in a 37%, 5% CO2 humidified incubator.

이후 시료를 5% 처리하고 20 hr 동안 반응하였다. After that, the sample was treated with 5% and reacted for 20 hr.

배지를 모두 제거하고 0.5 mg/ml MTT 시약을 처리하여 1 hr 동안 반응시켰다. All the medium was removed and 0.5 mg/ml MTT reagent was treated and reacted for 1 hr.

이후 MTT 용액을 제거한 후, 200 ul의 DMSO를 넣어 formazan 결정을 녹인후 분광광도계를 이용하여 590 nm에서 흡광도를 측정하였다. After removing the MTT solution, 200 ul of DMSO was added to dissolve formazan crystals, and absorbance was measured at 590 nm using a spectrophotometer.

그 결과를 HDF(Human deraml fibroblast)Cell은 표 2와 도 3, B16F0 Cell은 표 3과 도 4, RAW 264.7 cells은 표 4와 도 5에 나타내었다.The results are shown in Tables 2 and 3 for HDF (Human deraml fibroblast) cells, Tables 3 and 4 for B16F0 cells, and Tables 4 and 5 for RAW 264.7 cells.

Figure 112021091804447-pat00002
Figure 112021091804447-pat00002

Figure 112021091804447-pat00003
Figure 112021091804447-pat00003

Figure 112021091804447-pat00004
Figure 112021091804447-pat00004

실험예 3: NO 생성 억제 측정Experimental Example 3: Measurement of inhibition of NO production

상기 실시예 1과 실시예 2에서 얻어진 각 추출물의 항염 활성 효과를 확인해 보기 위해 염증 유발에 중요한 역할을 하는 것으로 알려진 NO생성에 대한 효과를 알아보았다. In order to confirm the anti-inflammatory activity of each extract obtained in Examples 1 and 2, the effect on NO production, which is known to play an important role in inducing inflammation, was investigated.

Nitric Oxide 측정은 cell의 supernatant에서의 NO의 양을 nitrite와 nitrate로서 측정하였다. Nitric oxide was measured as nitrite and nitrate in the amount of NO in the cell supernatant.

Nitrite에 대한 nitrate로 환원된 후의 안전한 형태인 griess reagent를 사용하였으며, 96 well plate (5 × 10⁴cells/well)에 RAW264.7 세포의 confluence가 80%일 때, PBS로 2번 washing한 후에 무혈청 배지를 사용하여 18 시간 이상 배양시킨 후에 시료를 농도별로 처리하여 1 시간 동안 배양한 후 lipopolysacchride (LPS) 1 μg/mL 처리하고 24 시간 동안 배양하였다. For nitrite, a safe form of griess reagent after reduction with nitrate was used. When the confluence of RAW264.7 cells is 80% in a 96 well plate (5 × 10⁴cells/well), after washing twice with PBS, serum-free medium After incubation for more than 18 hours using

배양액의 상층액을 취하여 griess 시약과 반응시킨 후 ELISA reader로 540 nm에서 흡광도를 측정하여 NO 생성율을 백분율로 표시하였다.After taking the supernatant of the culture medium and reacting it with griess reagent, the absorbance was measured at 540 nm with an ELISA reader, and the NO production rate was expressed as a percentage.

염증반응의 대표적인 인자인 NO의 생성 억제하는지 확인하기 위해 RAW264.7 세포에 lipopolysaccharide (LPS)를 1 μg/mL 처리한 다음 2 시간 뒤에 추출물을 각 농도별로 처리하였다. In order to check whether the production of NO, a representative factor of the inflammatory response, is inhibited, RAW264.7 cells were treated with 1 μg/mL of lipopolysaccharide (LPS), and then the extracts were treated for each concentration 2 hours later.

18 시간 동안 배양 후 배양액 내의 NO 양을 측정하였다. After incubation for 18 hours, the amount of NO in the culture was measured.

그 결과를 표 5와 도 6에 나타내었다.The results are shown in Table 5 and FIG. 6 .

Figure 112021091804447-pat00005
Figure 112021091804447-pat00005

실험예 4: Melanin assay 측정Experimental Example 4: Melanin assay measurement

상기 실시예 1 내지 2에서 제조한 각 혼합물의 멜라닌 생성 억제 효과를 확인하기 위해 Melanin assay을 진행하였다. In order to confirm the melanin production inhibitory effect of each mixture prepared in Examples 1 and 2, a melanin assay was performed.

B16F0(melanocyte)cells를 2.5 × 103 cells/well의 농도로 96 well plate에 분주하고 37%, 5% CO2 습윤 배양기에서 24 hr 동안 안정화 시킨 후 시료를 농도별로 처리하여 2 hr 동안 반응하였다. B16F0 (melanocyte) cells were dispensed in a 96-well plate at a concentration of 2.5 × 10 3 cells/well, stabilized in a 37%, 5% CO 2 humidified incubator for 24 hr, and samples were treated for each concentration and reacted for 2 hr.

반응 후 자극제인 α-MSH를 최종 농도가 100 nM이 되도록 희석하여 처리하였다. After the reaction, the stimulant, α-MSH, was diluted to a final concentration of 100 nM and treated.

72시간 후 배지로 방출된 멜라닌의 양을 분광광도계를 이용하여 405 nm에서 흡광도를 측정하여 계산하였다. The amount of melanin released into the medium after 72 hours was calculated by measuring the absorbance at 405 nm using a spectrophotometer.

그 결과를 표 6과 도 7에 나타내었다. The results are shown in Table 6 and FIG. 7 .

Figure 112021091804447-pat00006
Figure 112021091804447-pat00006

실험예 5: MMP-1 측정Experimental Example 5: Measurement of MMP-1

상기 실시예 1 내지 실시예 2에서 제조한 각 혼합물의 MMP-1의 mRNA를 확인하기 위해 Real time PCR을 진행하였다.Real-time PCR was performed to confirm the mRNA of MMP-1 in each mixture prepared in Examples 1 to 2.

HDF(Human deraml fibroblast)cells를 3 × 105 / 60 mm culture dish에 분주하고 37%, 5% CO2 습윤 배양기에서 18 hr 동안 안정화시킨후 serum free 배지로 교체하였다. HDF (Human deraml fibroblast) cells were aliquoted into 3 × 10 5 / 60 mm culture dishes, stabilized in a 37%, 5% CO 2 humidified incubator for 18 hr, and then replaced with a serum-free medium.

이후 시료를 5% 처리하고. 2시간 뒤에 UV-B를 10 mJ/cm2로 조사하여 20 hr 동안 반응하였다. 반응 후 세포를 NucleoZOL lysis buffer(NM, 740404)를 이용하여 harvest한 뒤, MN사에서 제공하는 protocol을 이용하여 RNA isolation을 진행 하였으며, 분리된 RNA를 microplate reader를 이용하여 정량한 뒤 HiSenScript™ RH(-) RT PreMix Kit(intron, 25087)을 이용하여 cDNA를 합성하였다. 5% of the sample was then treated. After 2 hours, UV-B was irradiated with 10 mJ/cm 2 and reacted for 20 hr. After the reaction, the cells were harvested using NucleoZOL lysis buffer (NM, 740404), RNA isolation was performed using the protocol provided by MN, and the isolated RNA was quantified using a microplate reader, followed by HiSenScript™ RH ( -) cDNA was synthesized using the RT PreMix Kit (intron, 25087).

합성된 cDNA와 2X Real-Time PCR Master Mix & Premix(BioFACT)를 이용하여 real-time PCR 수행후 증폭산물을 정량 분석하였다. PCR에 사용된 MMP-1, β-actin primer sequence는 표 7에 나타내었다. After performing real-time PCR using the synthesized cDNA and 2X Real-Time PCR Master Mix & Premix (BioFACT), the amplification products were quantitatively analyzed. The MMP-1 and β-actin primer sequences used for PCR are shown in Table 7.

그 결과를 표 8와 도 8에 나타내었다. The results are shown in Table 8 and FIG. 8 .

Figure 112021091804447-pat00007
Figure 112021091804447-pat00007

Figure 112021091804447-pat00008
Figure 112021091804447-pat00008

실시예 3 : 본 발명의 추출물을 함유하는 샴푸 제조 Example 3: Preparation of shampoo containing the extract of the present invention

95% 에탄올 5g에 암모늄라우레스설페이트 5g, 코실베타인 5g, 알킬에테르셀페이트 0.5g, 실리콘 0.5g, 폴리쿼터0.2g, 향료 0.2g, 보존제 0.02g를 혼합하였다.Ammonium laureth sulfate 5g, cosylbetaine 5g, alkyl ether sulfate 0.5g, silicone 0.5g, polyquater 0.2g, fragrance 0.2g, and preservative 0.02g were mixed with 95% ethanol 5g.

실시예에서 수득한 본 발명의 추출물 5g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 샴푸를 얻었다.5 g of the extract of the present invention obtained in Example and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added thereto, followed by stirring to obtain a shampoo.

실시예 4 : 본 발명의 추출물을 함유하는 화장수 제조Example 4: Preparation of lotion containing extract of the present invention

95% 에탄올 8g에 폴리피로리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합하였다. To 8 g of 95% ethanol, 0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of fragrance, 0.1 g of methyl paraoxybenzoate, a small amount of antioxidant, and a small amount of pigment were mixed.

실시예에서 수득한 본 발명의 추출물 10g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 화장수를 얻었다.10 g of the extract of the present invention obtained in Examples and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added thereto, followed by stirring to obtain a lotion.

실시예 5 : 본 발명의 추출물을 함유한 유액 제조Example 5: Preparation of emulsion containing extract of the present invention

세틸알콜1.2g, 스쿠알란 10g, 바세린 2g, 파라옥시안식향산에틸에스테르 0.2g, 글리세린모노에스테아레이드 1g, 폴리옥시에틸렌(20몰 부가)모노올레이트 1g및 향로 0.1g을 70℃에서 가열 및 혼합하여 용해하고, 실시예에서 수득한 본 발명의 추출물 0.1g, 디프로필렌글리콜 5g, 폴리에틸렌글리콜-1500 2g, 트리에탄올아민 0.2g, 정제수 76.6g을 75℃로 가열해서 용해하였다. 1.2 g of cetyl alcohol, 10 g of squalane, 2 g of vaseline, 0.2 g of paraoxybenzoic acid ethyl ester, 1 g of glycerin monoesterade, 1 g of polyoxyethylene (20 mol addition) monooleate and 0.1 g of incense furnace were heated and mixed at 70 ° C. After dissolving, 0.1 g of the extract of the present invention obtained in Examples, 5 g of dipropylene glycol, 2 g of polyethylene glycol-1500, 0.2 g of triethanolamine, and 76.6 g of purified water were heated to 75° C. and dissolved.

양자를 혼합하여 유화시킨 후 냉각하여 수중유(O/W)형의 유액을 얻었다.Both were mixed and emulsified, followed by cooling to obtain an oil-in-water (O/W) type emulsion.

실시예 6 : 본 발명의 추출물을 함유한 미용액 제조Example 6: Preparation of a cosmetic solution containing the extract of the present invention

95% 에틸알콜 5g에 폴리옥시에틸렌솔비탄모노올레이트 1.2g, 키툴로오즈 0.3g, 히아루론산나트륨 0.2g, 비타민 E-아세테이트 0.2g, 감초산 나트륨 0.2g, 파라옥시안식향산에틸에스테르 0.1g, 실시예에서 수득한 본 발명의 추출물 1g 및 적량의 색소를 혼합하여 미용액을 얻었다.95% ethyl alcohol 5g, polyoxyethylene sorbitan monooleate 1.2g, kitulose 0.3g, sodium hyaluronate 0.2g, vitamin E-acetate 0.2g, sodium licorate 0.2g, paraoxybenzoate ethyl ester 0.1g, practice 1 g of the extract of the present invention obtained in Example and an appropriate amount of a pigment were mixed to obtain a cosmetic solution.

이상의 설명으로부터, 본 출원이 속하는 기술분야의 당업자는 본 출원이 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 이와 관련하여, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적인 것이 아닌 것으로 이해해야만 한다. 본 출원의 범위는 상기 상세한 설명보다는 후술하는 청구범위의 의미 및 범위 그리고 그 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 출원의 범위에 포함되는 것으로 해석되어야 한다.From the above description, those skilled in the art to which the present application pertains will be able to understand that the present application may be embodied in other specific forms without changing the technical spirit or essential characteristics thereof. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of the present application should be construed as including all changes or modifications derived from the meaning and scope of the claims to be described later rather than the above detailed description and equivalent concepts thereof.

한국생명공학연구원Korea Institute of Bioscience and Biotechnology KCTC14478BPKCTC14478BP 2021022220210222

<110> HANKOOK COSMETICS MANUFACTURING CO., LTD. <120> Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract <130> Hankook-001 <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 871 <212> RNA <213> Unknown <220> <223> Lactobacillus kunkeei <400> 1 ctggcggcgt gcctaataca tgcaagtcga acgagctctc ccaaattgat tttatgcttg 60 cataaatgat ttttggattc ggagcgagtg gcgaactggt gagtaacacg tgggtaacct 120 gccccgaagc gggggataac atttggaaac aagtgctaat accgcataat tagttggaac 180 cgcatggttc caacttgaaa gatggctctg ctatcacttt gggatggacc cgcgccgtat 240 tagttagttg gtgagataaa agcccaccaa gacgatgata cgtagccgac ctgagagggt 300 aatcggccac attgggactg agacacggcc cagactccta cgggaggcag cagtagggaa 360 tcttccacaa tggacgaaag tctgatggag caacgccgcg tgagtgatga aggttttcgg 420 atcgtaaaac tctgttgtta aagaagaaca agtgttagag taactgttaa cactttgacg 480 gtatttaacc agaaagccac ggctaactac gtgccagcag ccgcggtaat acgtaggtgg 540 caagcgttgt ccggatttat tgggcgtaaa gcgagcgcag gcggttttgt aagtctgctg 600 tgaaagccct cagctcaact gaggaagtgc agtggaaact acaaaacttg agtacagaag 660 aggaaagtgg aactccatgt gtagcggtga aatgcgtaga tatatggaag aacaccagtg 720 gcgaaggcgg ctttctggtc tgttactgac gctgaggctc gaaagcatgg gtagcgaaca 780 ggattagata ccctggtagt ccatgccgta aacgatgaat actaggtgtt ggagggtttc 840 cgcccttcag tgccgcagct aacgcattaa g 871 <210> 2 <211> 734 <212> RNA <213> Unknown <220> <223> Lactobacillus kunkeei <400> 2 aggtgttgga gggtttccgc ccttcagtgc cgcagctaac gcattaagta ttccgcctgg 60 ggagtacgac cgcaaggttg aaactcaaag gaattgacgg gggcccgcac aagtggtgga 120 gcatgtggtt taattcgatg ctacgcgaag aaccttacca gctcttgaca tcttctgcca 180 acccaagaga ttgggcgttc ccttcgggga cagaatgaca ggtggtgcat ggttgtcgtc 240 agctcgtgtc gtgagatgtt gggttaagtc ccgcaacgag cgcaaccctt attattagtt 300 gccagcattt agttgggcac tctagtgaga ctgccggtga taaaccggag gaaggtgggg 360 acgacgtcaa atcatcatgc cccttatgag ctgggctaca cacgtgctac aatggatggt 420 acaacgagtc gcgaaaccgc gaggtcaagc taatctctta aagccattct cagttcggat 480 tgcaggctgc aactcgcctg catgaagttg gaatcactag taatcgtgga tcagcatgcc 540 acggtgaata cgttcccggg ccttgtacac accgcccgtc acaccatgag agtttgtaac 600 acccaaagac gatggggtaa ccttttagga gctagtcgtc taaggtggga cagatgatta 660 gggtgaagtc gtaacaaggt agccgtagga gaacctgcgg ctggatcacc ttcctttcta 720 cctggatctc ctcc 734 <110> HANKOOK COSMETICS MANUFACTURING CO., LTD. <120> Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract <130> Hankook-001 <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 871 <212> RNA <213> Unknown <220> <223> Lactobacillus kunkeei <400> 1 ctggcggcgt gcctaataca tgcaagtcga acgagctctc ccaaattgat tttatgcttg 60 cataaatgat ttttggattc ggagcgagtg gcgaactggt gagtaacacg tgggtaacct 120 gccccgaagc gggggataac atttggaaac aagtgctaat accgcataat tagttggaac 180 cgcatggttc caacttgaaa gatggctctg ctatcacttt gggatggacc cgcgccgtat 240 tagttagttg gtgagataaa agcccaccaa gacgatgata cgtagccgac ctgagagggt 300 aatcggccac attgggactg agacacggcc cagactccta cgggaggcag cagtagggaa 360 tcttccacaa tggacgaaag tctgatggag caacgccgcg tgagtgatga aggttttcgg 420 atcgtaaaac tctgttgtta aagaagaaca agtgttagag taactgttaa cactttgacg 480 gtatttaacc agaaagccac ggctaactac gtgccagcag ccgcggtaat acgtaggtgg 540 caagcgttgt ccggatttat tgggcgtaaa gcgagcgcag gcggttttgt aagtctgctg 600 tgaaagccct cagctcaact gaggaagtgc agtggaaact acaaaacttg agtacagaag 660 aggaaagtgg aactccatgt gtagcggtga aatgcgtaga tatatggaag aacaccagtg 720 gcgaaggcgg ctttctggtc tgttactgac gctgaggctc gaaagcatgg gtagcgaaca 780 ggattagata ccctggtagt ccatgccgta aacgatgaat actaggtgtt ggagggtttc 840 cgcccttcag tgccgcagct aacgcattaa g 871 <210> 2 <211> 734 <212> RNA <213> Unknown <220> <223> Lactobacillus kunkeei <400> 2 aggtgttgga gggtttccgc ccttcagtgc cgcagctaac gcattaagta ttccgcctgg 60 gggatacgac cgcaaggttg aaactcaaag gaattgacgg gggcccgcac aagtggtgga 120 gcatgtggtt taattcgatg ctacgcgaag aaccttacca gctcttgaca tcttctgcca 180 acccaagaga ttgggcgttc ccttcgggga cagaatgaca ggtggtgcat ggttgtcgtc 240 agctcgtgtc gtgagatgtt gggttaagtc ccgcaacgag cgcaaccctt attattagtt 300 gccagcattt agttgggcac tctagtgaga ctgccggtga taaaccggag gaaggtgggg 360 acgacgtcaa atcatcatgc cccttatgag ctgggctaca cacgtgctac aatggatggt 420 acaacgagtc gcgaaaccgc gaggtcaagc taatctctta aagccattct cagttcggat 480 tgcaggctgc aactcgcctg catgaagttg gaatcactag taatcgtgga tcagcatgcc 540 acggtgaata cgttcccggg ccttgtacac accgcccgtc acaccatgag agtttgtaac 600 acccaaagac gatggggtaa ccttttagga gctagtcgtc taaggtggga cagatgatta 660 gggtgaagtc gtaacaaggt agccgtagga gaacctgcgg ctggatcacc ttcctttcta 720 cctggatctc ctcc 734

Claims (5)

항산화, 항염, 미백, 항주름용 발효 추출물의 제조 방법에 있어서,
조직 배양으로 얻어진 산삼 배양근 100 중량부, 정제수 1,000 중량부를 추출용기에 투입하여 혼합한 후, 90℃에서 3시간 동안 추출하여 추출물을 수득하고,
상기 추출물을 121 ℃에서 15분 간 멸균한 후, 방냉한 뒤, 상기 방냉된 추출물에 기탁번호 KCTC 14478BP의 락토바실러스 쿤키 Hankook-001을 접종하여 35℃, 150rpm, 2일간 배양 발효하며, 상기 발효액을 10,000rpm에서 20분간 원심 분리하여 침전물과 유산균체를 제거한 후, 발효추출물을 제조하는 것을 특징으로 하되,
상기 기탁번호 KCTC 14478BP의 락토바실러스 쿤키 Hankook-001 균주의 배양 환경 조건은,
배양액의 pH는 5.8, 배양 시간은 44시간, 배양 온도는 32℃인 것을 특징으로 하며,
상기 발효추출물은,
화장료 조성물 전체 함량에 대해 0.01 ~ 10 중량% 함유되어 있는 것을 특징으로 하는 락토바실러스 쿤키 Hankook-001 균주를 이용한 항산화, 항염, 미백, 항주름용 발효추출물의 제조 방법.
In the method for producing a fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle,
100 parts by weight of cultured wild ginseng root obtained by tissue culture and 1,000 parts by weight of purified water were put into an extraction container and mixed, followed by extraction at 90° C. for 3 hours to obtain an extract,
After the extract was sterilized at 121 ° C. for 15 minutes, allowed to cool, and Lactobacillus kunki Hankook-001 of accession number KCTC 14478BP was inoculated into the cooled extract and cultured and fermented at 35 ° C., 150 rpm, 2 days, and the fermentation broth was After removing the sediment and lactic acid bacteria by centrifugation at 10,000 rpm for 20 minutes, characterized in that the fermentation extract is prepared,
The culture environment conditions of the Lactobacillus kunki Hankook-001 strain of the accession number KCTC 14478BP are,
It is characterized in that the pH of the culture medium is 5.8, the incubation time is 44 hours, and the culture temperature is 32°C,
The fermented extract is
A method for producing a fermentation extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunki Hankook-001 strain, characterized in that it is contained in an amount of 0.01 to 10% by weight based on the total content of the cosmetic composition.
제 1항에 있어서,
상기 화장료 조성물의 제형은,
샴푸, 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초화장료 제형;
수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이새도, 치크칼라 및 아이브로우펜슬류로 이루어진 색조화장료 제형; 중에서 선택되는 어느 하나인 것을 특징으로 하는,
락토바실러스 쿤키 Hankook-001 균주를 이용한 항산화, 항염, 미백, 항주름용 발효추출물의 제조 방법.
The method of claim 1,
The formulation of the cosmetic composition is,
Basic cosmetic formulations consisting of shampoo, lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O/W) type and water-in-oil (W/O) type;
a makeup base, foundation, skin cover, lipstick, lip gloss, face powder, two-way cake, eye shadow, cheek color, and eyebrow pencil of a water-in-water or water-in-oil type makeup base; characterized in that any one selected from
Method for producing a fermentation extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunki Hankook-001 strain.
삭제delete 삭제delete 삭제delete
KR1020210104865A 2021-08-09 2021-08-09 Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract KR102453319B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210104865A KR102453319B1 (en) 2021-08-09 2021-08-09 Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210104865A KR102453319B1 (en) 2021-08-09 2021-08-09 Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract

Publications (1)

Publication Number Publication Date
KR102453319B1 true KR102453319B1 (en) 2022-10-12

Family

ID=83597633

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210104865A KR102453319B1 (en) 2021-08-09 2021-08-09 Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract

Country Status (1)

Country Link
KR (1) KR102453319B1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910019600A (en) 1990-05-08 1991-12-19 김만경 Lactic acid bacteria culture medium for cosmetics with moisturizing and active oxygen removal ability
KR20130096604A (en) 2012-02-22 2013-08-30 아담휴 주식회사 Making method of facial moisturizer
KR20130115943A (en) 2012-04-13 2013-10-22 주식회사 알엔에이 Compisitiom for anti-inflammation, skin whitening and anti-aging comprising of supernatant of lactic acid bacteria lysate
KR20160013641A (en) * 2014-07-28 2016-02-05 홍소영 Novel Lactobacillus pentosus NEO 1 and extracts from ginseng-fermented products using Lactobacillus pentosus NEO 1 and manufacturing method thereof
KR101718465B1 (en) * 2016-01-08 2017-03-21 강희철 Novel Lactobacillus Casei GFC 1 and Extracts from Ginseng-fermented Products Using Lactobacillus Casei GFC 1 and Manufacturing Method Thereof
KR20180012647A (en) * 2016-07-27 2018-02-06 (주)지에프씨생명과학 Cosmetic composition including extract of fermented ginseng using lactobacillus casei gfc1 and manufacturing method for the same
KR20190091164A (en) * 2018-01-26 2019-08-05 (주)아모레퍼시픽 Cosmetic Composition for Improving Skin Condition Containing Ginseng Root Fermentation Extract
KR20190111890A (en) * 2017-06-09 2019-10-02 아사히 코우산 가부시키가이샤 New Lactic Acid Bacteria and Its Uses
US20190365828A1 (en) * 2016-12-28 2019-12-05 Yamada Bee Company, Inc. Fermented product and production method therefor

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910019600A (en) 1990-05-08 1991-12-19 김만경 Lactic acid bacteria culture medium for cosmetics with moisturizing and active oxygen removal ability
KR20130096604A (en) 2012-02-22 2013-08-30 아담휴 주식회사 Making method of facial moisturizer
KR20130115943A (en) 2012-04-13 2013-10-22 주식회사 알엔에이 Compisitiom for anti-inflammation, skin whitening and anti-aging comprising of supernatant of lactic acid bacteria lysate
KR20160013641A (en) * 2014-07-28 2016-02-05 홍소영 Novel Lactobacillus pentosus NEO 1 and extracts from ginseng-fermented products using Lactobacillus pentosus NEO 1 and manufacturing method thereof
KR101718465B1 (en) * 2016-01-08 2017-03-21 강희철 Novel Lactobacillus Casei GFC 1 and Extracts from Ginseng-fermented Products Using Lactobacillus Casei GFC 1 and Manufacturing Method Thereof
KR20180012647A (en) * 2016-07-27 2018-02-06 (주)지에프씨생명과학 Cosmetic composition including extract of fermented ginseng using lactobacillus casei gfc1 and manufacturing method for the same
US20190365828A1 (en) * 2016-12-28 2019-12-05 Yamada Bee Company, Inc. Fermented product and production method therefor
KR20190111890A (en) * 2017-06-09 2019-10-02 아사히 코우산 가부시키가이샤 New Lactic Acid Bacteria and Its Uses
KR20190091164A (en) * 2018-01-26 2019-08-05 (주)아모레퍼시픽 Cosmetic Composition for Improving Skin Condition Containing Ginseng Root Fermentation Extract

Similar Documents

Publication Publication Date Title
CN108567912B (en) Traditional Chinese medicine extract and enzymolysis and fermentation product thereof
JP2021020887A (en) Enhanced anti-aging cosmetic composition
KR101685581B1 (en) Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom
CN105362151A (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
KR101634668B1 (en) Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening
KR101930342B1 (en) A cosmetic composition
KR20120140141A (en) Cosmetic composition comprising the fermented extracts and the extracts of the rice
KR102101949B1 (en) A skin-care agent or cosmetics containig Antrodia camphorata fruit body extract or Antrodia camphorata mycelium extract
JP2023171950A (en) Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic
KR101841118B1 (en) Composition for skin external application comprising extract of scenedesmus sp.
KR101995557B1 (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR101587077B1 (en) Composition containing fermentated opuntia humifusa showing biological activity of skin
KR102453319B1 (en) Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract
KR102353995B1 (en) Cosmetic composition containing Nymphoides peltata and Centella asiatica fermented extract using Onyang hot spring water
KR20130027942A (en) Cosmetic composition comprising fermented extract of ilex paraguayensis
KR20110121775A (en) Cosmetic composition comprising the extract of thalictrum rochebrunianum as active ingredient
KR101843976B1 (en) Cosmetic composition comprising extract of geminated phaseolus radiatus fermented by aureobasidium pullulans
KR102390656B1 (en) A cosmetic composition comprising chlorella extract for skin-whitening
KR101806007B1 (en) Manufacturing method of cosmetic composition containing nano particle natural materials and cosmetic composition manufactured by the same
KR101803757B1 (en) Cosmetic composition containing natural complex fermented extracts
KR101997231B1 (en) Cosmetic composition containing enzyme-treated honey extract
KR101969684B1 (en) A cosmetic composition for anti-wrinkle and skin pore reduction containing natural spicule powder and natural complex extract
KR102098695B1 (en) Cosmetic Composition Containing Extracts of Morus Alba Root and Paeonia Suffruticosa Root
KR20110122448A (en) Cosmetic composition comprising the extract of filipendula formosa as active ingredient
KR102405854B1 (en) cosmetic composition for skin moisturizing and wrinkle improvement using Lactobacillus kunkeei Hankook-001strain

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant